China’s healthcare industry is facing huge challenges with issues such as government regulation uncertainties, downward pricing, impenetrable market access, transformative digital healthcare and increasing local competition. How can multinationals stay competitive and sustain growth in the world’s second largest market?

Please join AmCham Shanghai's Healthcare Committee event on Thursday, January 25, from 10:00-11:30am at the AmCham Shanghai Conference Room. Xu Jia, Partner, Operations Consulting, PwC Pharma/Healthcare Consulting Leading Partner of PwC, will give you a comprehensive overview on major trends in the healthcare, pharmaceutical, biomedical, healthcare services and life sciences from both commercial and policy aspects.

Members across the healthcare industry will learn:

· Pharma: gain greater insights on pricing structure changes from China’s government pricing
· Biomedical: understand policies and commercial changes and its impact on the industry
· Direct healthcare provider: access deeper market knowledge across the health industry
· Companies that support healthcare companies: find out the major challenges ahead and where strategic growth exists


10 AM - 10:15 AM
10:15 AM - 11 AM
11 AM - 11:30 AM


  • Xu Jia (Partner at PwC)

    Xu Jia

    Partner at PwC

    Xu Jia is a partner with a focus on the pharmaceutical, biotech and medical devices sector. Jia joined PwC in 2008 after working for Merck in Singapore for 8 years. She built up a broad experience in the pharmaceutical business: operational, quality, technical and business aspects and has a deep understanding of compliance, operations, supply chain, IT system and risk management. After joining PwC, Jia has been working with organizations to develop China strategy. Jia has led commercial due diligence, growth and capability assessment, execution of change and compliance system review projects (both quality and sales & marketing compliance).
    Jia has a PhD in Organic Chemistry and a bachelor’s degree in Chemistry. Jia was elected onto the executive board of ISPE Singapore Affiliate in 2008. She is also a board member of ISPE China. In 2010, Jia was granted the Top-Caliber Overseas Talent award by the Beijing Chaoyang District government.

    Relevant Experience includes:
    -Advised a global leading pharmaceutical to develop scalable and adaptable supply chain network to enable powerful go-to-market strategies and growth in Asia.
    -Developed market entry strategies for many mid-sized European/US pharmaceuticals in China.
    - Advised clients in major pharmaceutical deals from target searching, due diligence to post merge integrations.
    - Led team to help pharmaceuticals to enhance overall internal control and improve efficiency.
    - Led team to explore new business model for sales to interact with physicians in an effective but compliance manner.
    - Led team to design and roll out business solution to improve the compliance status in sales and marketing operation in China

    view more


A prepayment is required when choosing 'Standard Price'.

Member Ticket
Member Price Free
Member Company Employee Ticket
Standard Price RMB 100
Door Price RMB 100
Non-Member Ticket
Standard Price RMB 250
Door Price RMB 250